ECOG-ACRIN logoECOG-ACRIN logoECOG-ACRIN logoECOG-ACRIN logo
  • Home
  • Archives
  • Contact
✕
March 23, 2023
Person walking on directional sign
March 23, 2023
Categories
  • Editorials

Should I stay or should I go?

Many patients are unaware that stopping treatment during participation in a clinical trial does not automatically mean withdrawing from a clinical trial
Do you like it?
0 Read more
March 23, 2023
March 23, 2023
Categories
  • New Trials

The ComboMATCH precision medicine initiative is getting set to evaluate several new anti-cancer drug combinations

Hospitals and cancer centers nationwide are opening ComboMATCH on a rolling basis over the next few months
Do you like it?
0 Read more
March 23, 2023
March 23, 2023
Categories
  • Ongoing Trials

Video: Advocates discuss the EA2185 research study for patients with pancreatic cysts

Watch cancer research advocates Lisa Beckendorf and Steven Merlin discuss the EA2185 study for patients with pancreatic cysts
Do you like it?
0 Read more
March 23, 2023
Doctor talking with older male patient
March 23, 2023
Categories
  • Ongoing Trials

Ongoing Trials: A closer look at ECOG-ACRIN’s myeloma studies

These two trials are exploring new treatment approaches for adults with multiple myeloma
Do you like it?
0 Read more
March 23, 2023
Research dictionary entry
March 23, 2023
Categories
  • Trial Results

Trial Results: ECOG-ACRIN research round-up – Winter 2023

Summaries of recently reported ECOG-ACRIN research results
Do you like it?
0 Read more

News, editorials, and perspectives for the cancer research advocacy community

✕

Categories

  • Editorials
  • New Trials
  • Ongoing Trials
  • Trial Results

Resources

  • Active ECOG-ACRIN Trials
  • Advocacy Organizations
  • Myths and Facts
STAY UP TO DATE

Subscribe to receive updates from the ECOG-ACRIN advocacy committee.

Select list(s) to subscribe to


By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact


Office of Communications
1818 Market Street, Suite 3000
Philadelphia, PA 19103
Phone: 215.789.3631
www.ecog-acrin.org

Contact us with any questions

© 2019-2026 ECOG-ACRIN Cancer Research Group. All Rights Reserved. Designed by Create & Associates, Inc